Birkenfeld, July 30, 2024
STRATEC SE, a leading manufacturer of automation solutions for partners in clinical diagnostics and life sciences, is reporting a change in the composition of its Board of Management.
In agreement with the company, Dr. Robert Siegle, a member of the Board of Management of STRATEC SE, will stand down from his position on the Board of Management and leave the company as of August 31, 2024.
Prof. Dr. Georg Heni, Chairman of the Supervisory Board, thanks Dr. Robert Siegle on behalf of STRATEC SE for his longstanding and successful commitment to the company. During his time as a member of the Board of Management, Dr. Siegle has made a major contribution to the company’s successful development.
Dr. Siegle’s tasks will be performed by Oliver Albrecht, who will act in the capacity of an interim CFO. Oliver Albrecht has a long track record of experience and great expertise in leading finance departments at listed technology companies with an international focus. He was most recently Chief Financial Officer at the listed company SÜSS MicroTec SE from 2019 to 2023.
